Home / Recalls / Partell Specialty Pharmacy / D-0637-2018

D-0637-2018 Class II Terminated

Recalled by Partell Specialty Pharmacy — Las Vegas, NV

Recall Details

Product Type
Drugs
Report Date
April 25, 2018
Initiation Date
March 22, 2018
Termination Date
January 15, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 vials

Product Description

CoEnzymeQ10 25mg/mL, 5mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.

Reason for Recall

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Distribution Pattern

NV only

Code Information

Lot#: 20171227@14, BUD 03/27/2018; 20180205@37, BUD 05/06/2018; 20180214@30, BUD 05/15/2018.

Other recalls by Partell Specialty Pharmacy

  • D-0642-2018 Class II — Methionine 25mg/Inositol 50mg/Choline 50mg/ B12 1mg, packaged in a) 5 mL amber v (March 22, 2018)
  • D-0658-2018 Class II — TM #4 (ALP 20/PAPAV/PHENT 2), 3 mL amber vial, Rx only, Partell Specialty Pharma (March 22, 2018)
  • D-0663-2018 Class II — Testosterone 100 mg pellet packaged in amber vial, Rx only, Partell Specialty (March 22, 2018)
  • D-0641-2018 Class II — Methionine15mg/Inositol 50mg/Choline 100mg, packaged in a) 5mL and b) 50 mL ambe (March 22, 2018)
  • D-0644-2018 Class II — Testosterone Cypionate 200mg/mL, 5 mL amber vial, Rx only, Partell Specialty Pha (March 22, 2018)
  • D-0634-2018 Class II — Ascorbic Acid (Tapioca) 500 mg/mL, 50 mL amber vial, Rx only, Partell Specialt (March 22, 2018)
  • D-0679-2018 Class II — Estradiol 40 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, (March 22, 2018)
  • D-0670-2018 Class II — Testosterone/Anastrozole 200 mg/20 mg pellets packaged in amber vial, Rx only, P (March 22, 2018)
  • D-0659-2018 Class II — TM #6 (ALP 25/PAPAV/PHENT1), 3 mL amber vial, Rx only, Partell Specialty Pharm (March 22, 2018)
  • D-0643-2018 Class II — Nandrolone decanoate 200mg/mL, 5 mL amber vial, Rx only, Partell Specialty Pharm (March 22, 2018)